SG Americas Securities LLC Has $13.95 Million Stock Holdings in Globe Life Inc. $GL

SG Americas Securities LLC boosted its holdings in shares of Globe Life Inc. (NYSE:GL) by 909.6% in the fourth quarter, Holdings Channel reports. The firm owned 99,746 shares of the company’s stock after purchasing an additional 89,866 shares during the quarter. SG Americas Securities LLC’s holdings in Globe Life were worth $13,950,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of GL. RF&L Wealth Management LLC raised its holdings in shares of Globe Life by 51.9% in the 4th quarter. RF&L Wealth Management LLC now owns 3,903 shares of the company’s stock worth $546,000 after buying an additional 1,334 shares in the last quarter. Dynamic Advisor Solutions LLC bought a new position in shares of Globe Life during the 4th quarter worth approximately $937,000. Dagco Inc. boosted its stake in Globe Life by 86.7% in the 4th quarter. Dagco Inc. now owns 631 shares of the company’s stock valued at $88,000 after buying an additional 293 shares in the last quarter. CWA Asset Management Group LLC grew its position in Globe Life by 20.1% in the fourth quarter. CWA Asset Management Group LLC now owns 36,516 shares of the company’s stock valued at $5,107,000 after acquiring an additional 6,116 shares during the period. Finally, Avior Wealth Management LLC grew its position in Globe Life by 15.7% in the fourth quarter. Avior Wealth Management LLC now owns 3,240 shares of the company’s stock valued at $453,000 after acquiring an additional 440 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on GL. JPMorgan Chase & Co. lifted their price objective on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Evercore set a $157.00 target price on shares of Globe Life in a research report on Wednesday, February 18th. Wells Fargo & Company lifted their price target on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. TD Cowen restated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Finally, Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $172.00.

Insider Activity at Globe Life

In related news, EVP Michael Clay Majors sold 30,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $146.89, for a total value of $4,406,700.00. Following the completion of the sale, the executive vice president owned 47,066 shares of the company’s stock, valued at $6,913,524.74. This trade represents a 38.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the transaction, the chief executive officer owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This trade represents a 25.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 82,807 shares of company stock valued at $12,041,286 in the last three months. 1.51% of the stock is currently owned by corporate insiders.

Globe Life Price Performance

Shares of GL stock opened at $135.26 on Friday. The stock’s fifty day moving average is $141.45 and its 200-day moving average is $138.84. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a market capitalization of $10.61 billion, a PE ratio of 9.61 and a beta of 0.46. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.0%. Globe Life’s dividend payout ratio (DPR) is currently 7.67%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.